Lisa Hoogendam is a Researcher at Erasmus MC specializing in Plastic and Reconstructive Surgery and Hand Surgery . Her work focuses on improving patient outcomes in hand surgery and arthritis management. Key areas: Osteoarthritis, Thumb Injuries, Shared Decision-Making Collaborations: Hand-Wrist Study Group, Outcome-Based Healthcare Research Group Her research emphasizes surgical techniques, patient-reported outcomes, and cost-effectiveness analyses. Recent publications include studies on tendon autografts, ligament reconstructions, and outcome-driven consultations. Scientific trends in her work involve hand surgery innovations , patient experience optimization , and health economics in clinical decision-making.
Asst. Prof. Görkem ÇİTOĞLU is affiliated with USKUDAR UNIVERSITY's Faculty of Medicine, Department of Cardiovascular Surgery. He completed his MD at İstanbul Yeditepe University (2009), specialty training at İstanbul University (2015), and subspecialty in Pediatric Cardiovascular Surgery at Kartal Koşuyolu Yüksek İhtisas Hospital. His roles include instructorship at Bursa Uludağ University (2019-2020) and work at Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center (2020-2022). Education: İstanbul Yeditepe University Faculty of Medicine (MD 2009) Specialty: İstanbul University İstanbul Faculty of Medicine (2015) Subspecialty: Kartal Koşuyolu Yüksek İhtisas Hospital (Children Cardiovascular Surgery) Research focuses on pediatric cardiac surgical innovations including telemetric pulmonary artery banding, atrioventricular septal defect repair, and coarctation management. Contributed to multicenter databases analyzing 2,307 pediatric cases. Published 1 national article during 2019-2020 service, plus 2 book chapters and assisted in 3 international articles/1 book chapter during 2020-2022. Key clinical areas: Postoperative intensive care for newborns undergoing pulmonary artery banding/aortopulmonary shunt, congenital cardiac surgery outcomes, and surgical technique optimization.
Professor Piotr Czauderna is the Head of the Department of Surgery and Urology for Children and Adolescents at the Medical University of Gdańsk, Poland. He holds a prominent role in pediatric surgical oncology, specializing in hepatoblastoma, liver tumors, and clinical oncology. His work emphasizes international collaboration through initiatives like the Children’s Hepatic tumors International Collaboration (CHIC) database, which drives research into pediatric liver malignancies. Research interests include risk stratification in hepatoblastoma, molecular characterization of pediatric liver cancers, and optimizing surgical techniques for pediatric patients. His contributions extend to humanitarian efforts, including establishing systems to evacuate Ukrainian war-affected children for specialized medical care. Key achievements include over 582 publications, 6 promoted theses, and leadership in teams focusing on AI in healthcare and cancer management optimization. His work bridges clinical practice, research, and global health crises response, with a focus on improving outcomes for children with rare and complex malignancies. He actively participates in European research networks (ERN eUROGEN) and has pioneered protocols for pediatric surgical training and crisis-driven healthcare coordination.
Dr. Melina J Windon is an Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Kentucky College of Medicine. She is a board-certified head and neck oncologic and microvascular reconstructive surgeon with expertise in treating complex neoplasms of the head and neck region. Education: Bachelor of Arts in Biology, Messiah College (2006–2009) Doctor of Medicine, University of Connecticut School of Medicine (2011–2015) General Surgery Internship, Geisinger Medical Center (2015–2016) Otolaryngology-Head and Neck Surgery Residency, Johns Hopkins University (2017–2022) NIH T32 Research Training in Otolaryngology Fellowship, University of Michigan (2022–2023) Dr. Windon’s research interests center on public health and the epidemiology of head and neck cancers, particularly those associated with HPV. Her clinical work involves transoral robotic surgery (TORS), microvascular reconstructive techniques, and surgical management of complex defects due to cancer or trauma. She specializes in a wide range of procedures including thyroidectomy, neck dissection, glossectomy, maxillectomy, and free flap reconstruction. She has authored numerous peer-reviewed articles and book chapters in the field of head and neck oncology. Her training at premier institutions and her focus on both surgical innovation and population health reflect a strong commitment to advancing patient care and academic medicine. Scientific Awards: Multiple awards and honors during medical and surgical training Dr. Windon is actively engaged in clinical research and surgical practice. She has no listed advisees in the provided text, but her role as an assistant professor suggests involvement in medical education and mentorship. She completed an NIH T32 Research Fellowship, indicating prior grant support and research training. Her clinical and research work is supported by her affiliation with the University of Kentucky’s otolaryngology department, where she contributes to a multidisciplinary team focused on head and neck oncology and reconstructive surgery.
Ross T. Whitaker is a Professor and Director of the School of Computing at the University of Utah, where he is also a faculty member of the Scientific Computing and Imaging (SCI) Institute. He has been a key figure in advancing computational methods in medical imaging, geometry processing, and scientific visualization. University: University of Utah School: School of Computing Institute: Scientific Computing and Imaging (SCI) Institute Education: B.S. in Electrical Engineering and Computer Science, Princeton University (Summa Cum Laude, 1986) Ph.D. in Computer Science, University of North Carolina at Chapel Hill (1994) Research Interests: Ross Whitaker's research spans image analysis, statistical shape modeling, GPU-based PDEs, level-set methods, and uncertainty visualization. His work emphasizes adaptive, data-driven models for image denoising, segmentation, and reconstruction, often using nonparametric statistics and information-theoretic principles. He has pioneered methods in tetrahedral meshing, particle systems for surface sampling, and manifold learning. Recent Publication Trends: His recent publications (2020–2025) highlight a strong focus on statistical shape analysis in medical applications, particularly in metopic craniosynostosis , using tools like DeepSSM and CranioRate . There is a growing emphasis on deep learning, explainable AI, and multimodal sensing (e.g., audio-visual detection of idling vehicles). His interdisciplinary work bridges computer science, biomedical engineering, and environmental health. Scientific Awards: IEEE Fellow NSF Career Award Alumni Scholarship Award (UNC Chapel Hill) Advising and Grants: He leads a graduate research group in image analysis and scientific computing, mentoring students like Miriah Meyer (Ph.D. 2010). His projects are supported by federal agencies and industrial contracts, focusing on shape modeling, medical imaging, and environmental monitoring. He has developed influential software such as ShapeWorks, Seg3D, Cleaver, and contributed to ITK. Labs and Teams: He is a core member of the SCI Institute, a leading interdisciplinary research center in scientific computing and visualization. His team develops computational tools for biomedical image analysis and uncertainty quantification, with applications in surgery, diagnostics, and public health.
Dr. Aude Nassif is a dermatologist and researcher at the Pasteur Institute Medical Center in Paris, where she has worked since 2000. She specializes in Hidradenitis Suppurativa (HS) research and clinical management, serving as Principal Investigator for the REVE-Pasteur project, a register of HS patients at the Pasteur Institute Medical Center. Dr. Nassif has developed expertise in both the genetic and microbiological aspects of HS, collaborating extensively with researchers from Necker-Enfants Malades hospital. Medical studies at University of Angers (1975-1982) Residency in Dermatology at Reims and Tarnier-Cochin, Paris (1982-1988) Board certified in Dermatology (1988) Chief residency in Dermatology at Rouen (1988-1989) Medical training in USA (1989-1992), including fellowship at Oregon Health Sciences University with Dr. Jon Hanifin Worked as dermatologist at Croix-Saint Simon Hospital and Tarnier-Cochin Hospital (1993-2003) Dr. Nassif's primary research focus is on Hidradenitis Suppurativa, with particular interest in the genetic and microbiological aspects of the disease. She has been involved in HS genetic studies since 2006 and microbiological studies since 2007. Her work has led to the development of a new antibiotic strategy targeted according to microbiology of lesions, allowing prolonged remission of HS in combination with surgery. She also investigates hormonal influences and sexual dimorphism in HS as part of the SHINE-HS project and collaborates on metabolomic and immunologic studies of HS lesions. Dr. Nassif's publication record demonstrates consistent focus on advancing HS understanding and treatment approaches. Her research spans genetic studies, microbiological analyses, clinical treatment strategies, diagnostic improvements, and disease severity assessment. She has contributed to the development of new antibiotic protocols and scoring systems for HS, while investigating paradoxical reactions to biologic agents in HS patients. Her work often involves collaborative efforts across multiple French institutions. Dr. Nassif has secured multiple research grants related to HS, with the team obtaining 8 academic grants over the past 10 years (3 from SFD, 3 from FRM, 1 PHRC and 1 from Pasteur Institute). She collaborates with several prominent researchers including Dr. Maia Delage Toriel, Dr. Join-Lambert, Dr. Duchatelet, and Pr. Hovnanian. Her laboratory work focuses on understanding the complex interplay between host genetics, microbiome, and immune responses in HS pathogenesis.
Genadijs Trofimovičs is an Associate Professor and Teaching Coordinator at the Department of Surgery, Faculty of Medicine, Riga Stradiņš University, concurrently practicing as a surgeon at P. Stradiņš University Hospital. His academic journey includes a medical degree (1980), postgraduate surgical training (1983-1985), and a Dr.med. (1989) from Riga Medical Institute. Research Focus: His work centers on surgical oncology, hereditary cancer genetics (BRCA1/2, CDH1), breast cancer subtyping, and surgical outcomes. Key interests include genetic susceptibility in Latvian populations, breast reconstruction efficacy, and minimally invasive diagnostics. Publication Trends: Recent articles (2013-2019) emphasize BRCA1/2-driven breast cancer prognostics, CDH1 variants in gastric cancer, and innovations in surgical techniques. Genetics and biomarker validation are recurring themes. Advising & Grants: Supervised 2 doctoral theses (BRCA1/triple-negative breast cancer; gastric cancer molecular profiles) and 2 student projects. Consulted for EU cross-border projects: (1) Hereditary cancer awareness in Baltic regions (Interreg IIIB, 2008-2010), (2) Breast cancer prevention initiatives (ENPI CBC, 2012).
Maria Papadaki is an Associate Professor in Oral & Maxillofacial Surgery at the European University of Cyprus's School of Dentistry. She holds dual academic and clinical roles, with affiliations including the Medical School of Heraklion, Crete, and Harvard Medical School. Her career spans academic, clinical, and research roles in craniofacial surgery with over 25 years of experience. PhD in Distraction Osteogenesis (2009) MD from Aristotle University (2004) Specialization in Pediatric Oral Surgery (2006) Her research focuses on craniofacial surgical innovations including distraction osteogenesis devices, sialoendoscopy, and vascular anomaly treatments. She has pioneered animal models for maxillary and mandibular distraction osteogenesis studies. Active in academic governance, she serves as a reviewer for major journals and led NIH-funded research projects on biomaterials and surgical devices. Research highlights include developing CO2 laser bone welding techniques, evaluating radiation exposure in dental imaging, and investigating novel treatments for cherubism. Her work bridges surgical innovation with clinical practice through 60+ peer-reviewed publications and 12 active research projects as Principal Investigator/Co-Investigator. Awards include recognition for distraction osteogenesis histological research (2008). Teaching contributions include instructor roles at Harvard School of Dental Medicine (2004-2012) and surgical training programs at Massachusetts General Hospital. Her academic service includes leadership in animal research ethics and laboratory management. Current research emphasizes minimally invasive techniques, biomaterial applications, and advancing surgical technologies through interdisciplinary collaboration.
Christodoulos Laspos is an Assistant Professor in the Department of Dentistry at the European University of Cyprus's School of Dentistry. He specializes in orthodontics with a focus on craniofacial disorders, cleft lip and palate treatment, and obstructive sleep apnea management. His academic journey includes a DDS from the University of Athens (1995), an MDS from the University of Tennessee (1999), and advanced training in craniofacial orthodontics at the University of Texas Southwestern Medical Center (2000). Research interests span presurgical orthopedics for cleft patients, mandibular advancement devices for sleep apnea, and reconstructive surgery techniques for craniofacial anomalies. He has published widely on topics including palatal expander repair, cleft-related speech deficiencies, and skeletal asymmetry analysis in noncleft and cleft populations. His work integrates clinical practice with multidisciplinary approaches to address complex craniofacial conditions. Education: DDS, University of Athens School of Dentistry (1995) MDS, University of Tennessee Dental School (1999) Craniofacial Orthodontics, University of Texas Southwestern (2000) He served as President of the European Orthodontic Society (2021–2022) and held roles in the Cyprus Orthodontic Society's Scientific Committee (2004–2012) and European Orthodontic Society Council (2014–2022). His publications include book chapters on pediatric dentistry and peer-reviewed articles in journals like Odontostomatological Progress and Cleft Palate Journal . Current initiatives include a forthcoming Springer book on presurgical infant orthopedics and contributions to cleft lip/palate surgical protocols. His research emphasizes translational applications of orthodontic innovations to improve patient outcomes in craniofacial reconstruction and sleep-related disorders.
Vincent Vander Poorten serves as a full Professor at KU Leuven's Faculty of Medicine, Department of Oncology, where he leads the Head and Neck Oncology unit at UZ Leuven. He holds significant institutional roles including membership in the Council of the Faculty of Medicine, the Council of the Department of Oncology, and the Programme Committee for Deglutology. As part of the KU Leuven Cancer Institute (LKI), his work bridges clinical practice with cutting-edge research in head and neck malignancies. Professor Vander Poorten's research focuses on surgical oncology for head and neck cancers with particular expertise in salivary gland tumors, minimally invasive techniques, and translational research. His current projects include international collaborative evaluation of aggressive salivary gland neoplasms (2025-2029), novel applications for immune checkpoint blockers in head and neck cancer (2018-2024), and a clinical sabbatical focused on advancing minimally invasive oncological surgical techniques (2024). His work emphasizes improving surgical outcomes while developing evidence-based approaches for rare tumors including anterior skull base malignancies. Analysis of Vander Poorten's 2025 publications reveals a strong thematic focus on salivary gland carcinoma management, oral squamous cell carcinoma outcomes, and innovative surgical techniques. His research demonstrates extensive international collaboration across European institutions including Padua, Pisa, Genova, and Auckland, with significant contributions to clinical validation studies, systematic reviews, and surgical innovation. The publications consistently address critical challenges in head and neck oncology including lymph node metastasis classification, postoperative complications, and long-term functional outcomes. As Head of the Head and Neck Oncology unit, Vander Poorten supervises multiple research initiatives and leads a multidisciplinary team focused on comprehensive cancer care. His clinical sabbatical project involved establishing international partnerships for translational research on salivary gland carcinomas and anterior skull base tumors, while the AIRCARE project (AI-augmented Robotics for Cancer point of caRE) demonstrates his commitment to integrating technological innovation with surgical practice. His teaching responsibilities span multiple courses including Topographic Anatomy, Integrative Oncology, and Problem-Solving in ENT and Head and Neck Surgery.
Anders Enocson is an Adjunct Professor of Orthopedic Traumatology at the Karolinska Institutet , leading the Orthopedics Research Group at the Department of Molecular Medicine and Surgery. He combines academic research with clinical practice as a senior physician at Karolinska University Hospital. Specialist in orthopedic surgery since 2007 First professor in orthopedic traumatology in Sweden (2020) Extensive clinical experience across Sweden and UK Research focus: Trauma epidemiology, fracture outcomes, and AI applications His research spans: Trauma Registry Karolinska - Data-driven quality improvement SweTrau - National trauma registry machine learning models Pelvic Fractures - Complication reduction strategies Tendon Repair - Mechanobiology and neuropeptide regulation Medical Imaging - CT motion analysis for fractures Orthopedic Oncology - Sarcoma treatment outcomes Key publication trends show emphasis on Machine learning for mortality prediction 3D CT analysis in fracture follow-up Long-term joint replacement outcomes Postoperative complication risk factors Tendon healing biomarkers Clinical collaborations include AO Foundation courses in Sweden Karolinska Traumacentrum leadership International orthopedic networks Multidisciplinary teams in trauma care
Dieter Lindskog, MD, is an Associate Professor of Orthopaedics and Rehabilitation at Yale School of Medicine, where he serves as Section Chief of Musculoskeletal Oncology and Disease Aligned Research Team Leader for the Sarcoma Program at Yale Cancer Center. His clinical expertise focuses exclusively on benign/malignant bone/soft tissue tumors and metastatic bone disease. Education: BA, Yale University (1993) MD, New York Medical College (1998) Residency: Yale-New Haven Hospital (2003) Fellowship: University of Florida - Shands Teaching Hospital (2004) Research Focus: Dr. Lindskog's investigations center on improving outcomes for reconstructive techniques post-sarcoma resection and developing minimally invasive treatments for benign bone lesions. His work spans clinical oncology, biomechanics, and surgical innovation, with emphasis on metastatic disease management and sarcoma therapeutics. Publication Trends: Recent articles (2018-2025) demonstrate a strong focus on metastatic bone disease interventions, comparative sarcoma outcomes, and minimally invasive techniques. Key themes include ablation-osteoplasty-reinforcement procedures, intramedullary nailing efficacy, and database analyses of sarcoma behavior. Leadership & Service: Director, Smilow Cancer Hospital Sarcoma Tumor Board Associate Program Director, YNHH Orthopedic Residency Member: NCCN Bone Cancer Panel, MusculoSkeletal Tumor Society Fellowship Committee AAOS Musculoskeletal Tumor & Metabolic Disease Program Committee
Kenya M. Williams, MD, is an Assistant Professor in the Department of Ophthalmology at Rush Medical College, Rush University. She specializes in oculoplastic and reconstructive surgery of the periorbital region, with clinical practice sites in Chicago and Evanston. Her clinical expertise includes blepharoplasty, oculoplastic surgery, orbital diseases, thyroid eye disease, tear duct disorders, wound reconstruction, and minimally invasive treatments such as Botox and dermal fillers. She emphasizes functional restoration, believing that "form follows function" , resulting in natural cosmetic outcomes post-surgery. Dr. Williams completed her ophthalmology residency at the State University of New York (SUNY) and pursued fellowship training in Ophthalmic Plastic Surgery at Medical College of Pennsylvania/Allegheny General Hospital. She earned her medical degree from Chicago Medical School. Her practice philosophy centers on preserving or improving vision while restoring normal eyelid structure and function. Though academic publications and research are noted as part of Rush clinicians' activities, no specific articles or research projects are detailed in the available text. She is not listed as having received any specific scientific awards or honors in the provided content. There is no mention of student advising, grant funding, or leadership in research labs or teams. As an independent practitioner, she is not an employee of Rush but chooses to treat patients at Rush-affiliated facilities.
Thomas Dohlman is an Assistant Professor of Ophthalmology at Harvard Medical School , affiliated with the Department of Ophthalmology at Boston Children's Hospital. He earned his MD from the University of Massachusetts Medical School and holds a BS from MIT. Education BS, Massachusetts Institute of Technology MD, University of Massachusetts Medical School Dr. Dohlman is a clinician-scientist specializing in corneal and external eye diseases , with active research in corneal immunology , transplantation , and ocular surface disorders . His work bridges basic science and clinical applications, focusing on immune modulation in graft survival and fibrosis prevention. Recent publications highlight his expertise in uveitis treatment , limbal stem cell transplantation , and neurotrophic keratopathy . He employs murine models to study transplantation immunology and develops novel therapies like alpha-Melanocyte Stimulating Hormone for corneal protection. Dr. Dohlman's clinical practice includes managing pediatric corneal diseases , dry eye , and ocular trauma . He is part of Boston Children's Hospital's multidisciplinary ophthalmology team with national leadership in pediatric cataract surgery and retinal disease management. Key Research Trends Immune regulation in corneal grafts Neuropeptide-based ocular therapies Stem cell applications for ocular surface repair Epidemiology of corneal opacity Anti-vascular endothelial growth factor treatments
Karen Lesley Guerrero is a Consultant Urogynaecologist at NHS Greater Glasgow and Clyde and Honorary Senior Clinical Lecturer at the University of Glasgow Medical School. Her clinical and academic work focuses on pelvic floor disorders, with particular expertise in pelvic organ prolapse and urinary incontinence management. Her research interests center on innovative treatments for pelvic floor disorders, including: Pelvic organ prolapse interventions Urinary incontinence management strategies Comparative effectiveness of surgical techniques Self-management approaches for chronic conditions Women's urological health outcomes Her work emphasizes evidence-based practice and patient-centered care models. Dr. Guerrero's publications demonstrate consistent focus on pelvic floor disorders, with recent work examining pessary self-management, pelvic floor muscle training efficacy, and surgical alternatives for incontinence. Her research spans clinical trials, qualitative studies, and health services implementation. Scientific recognition includes: National Health Research Senior Fellow She leads major NIHR-funded trials including TOPSY (pessary self-management), FUTURE (urodynamics evaluation), and OPAL (pelvic floor muscle training). Her work involves multidisciplinary collaboration across NHS Scotland, UK Continence Society, and international research networks. As Chair of the UK Continence Society Executive Board, she influences national policy and clinical guidelines. Her laboratory and team work centers on the PROPEL realist evaluation project implementing evidence-based pelvic floor muscle training, working with implementation scientists, physiotherapists, and patient groups to optimize care delivery models for pelvic organ prolapse.
